Inventor · disambiguated record
Bret Berner
Also filed as: BERNER BRET
71 granted patents·42 pending applications·9,839 citations·filing 1986–2025
99Inventor score
Files withDEPOMED INC31TEIKOKU PHARMA USA INC16BERNER BRET15CYGNUS THERAPEUTIC SYSTEMS9SAGE THERAPEUTICS INC6
Top patents by PatentIndex Score
113 records- 0199US6488962B1Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage formsDEPOMED INC·Filed 2000·Granted Dec 3, 2002·442 cites·27 claims
- 0298US7731989B2Gastric retained gabapentin dosage formDEPOMED INC·Filed 2008·Granted Jun 8, 2010·22 cites·20 claims
- 0398US6595919B2Device for signal processing for measurement of physiological analytesCYGNUS THERAPEUTIC SYSTEMS·Filed 2001·Granted Jul 22, 2003·1.3k cites·49 claims
- 0498US6233471B1Signal processing for measurement of physiological analysisCYGNUS THERAPEUTIC SYSTEMS·Filed 1999·Granted May 15, 2001·1.5k cites·44 claims
- 0597US11236121B2Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroidSAGE THERAPEUTICS INC·Filed 2017·Granted Feb 1, 2022·23 cites·5 claims
- 0697US7295867B2Signal processing for measurement of physiological analytesANIMAS CORP·Filed 2003·Granted Nov 13, 2007·901 cites·30 claims
- 0797US6850790B2Monitoring of physiological analytesCYGNUS THERAPEUTIC SYSTEMS·Filed 2003·Granted Feb 1, 2005·798 cites·27 claims
- 0897US6356776B1Device for monitoring of physiological analytesCYGNUS THERAPEUTIC SYSTEMS·Filed 2000·Granted Mar 12, 2002·627 cites·51 claims
- 0996US8329215B2Shell and core dosage form approaching zero-order drug releaseBERNER BRET·Filed 2011·Granted Dec 11, 2012·32 cites·24 claims
- 1096US8192756B2Gastric retained gabapentin dosage formBERNER BRET·Filed 2011·Granted Jun 5, 2012·29 cites·18 claims
- 1196US7976870B2Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tractDEPOMED INC·Filed 2004·Granted Jul 12, 2011·82 cites·23 claims
- 1296US7438927B2Methods of treatment using a gastric retained gabapentin dosageDEPOMED INC·Filed 2003·Granted Oct 21, 2008·56 cites·67 claims
- 1396US6594514B2Device for monitoring of physiological analytesCYGNUS THERAPEUTIC SYSTEMS·Filed 2001·Granted Jul 15, 2003·425 cites·51 claims
- 1496US6144869AMonitoring of physiological analytesCYGNUS THERAPEUTIC SYSTEMS·Filed 1999·Granted Nov 7, 2000·818 cites·47 claims
- 1595US11884696B2Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroidSAGE THERAPEUTICS INC·Filed 2021·Granted Jan 30, 2024·4 cites·19 claims
- 1695US8945619B2Shell-and-core dosage form approaching zero-order drug releaseDEPOMED INC·Filed 2012·Granted Feb 3, 2015·28 cites·23 claims
- 1795US8119166B2Methods of treatment using a gastric retained gabapentin dosageBERNER BRET·Filed 2009·Granted Feb 21, 2012·10 cites·19 claims
- 1895US8043630B2Shell-and-core dosage form approaching zero-order drug releaseDEPOMED INC·Filed 2010·Granted Oct 25, 2011·26 cites·20 claims
- 1995US7174199B2Monitoring a physiological analytesANIMAS TECHNOLOGIES LLC·Filed 2004·Granted Feb 6, 2007·318 cites·20 claims
- 2095US6999810B2Biosensor and methods of use thereofANIMAS TECHNOLOGIES LLC·Filed 2004·Granted Feb 14, 2006·352 cites·44 claims
- 2195US6068853ATemporally controlled drug delivery systemsNOVARTIS AG·Filed 1995·Granted May 30, 2000·200 cites·14 claims
- 2294US6816742B2Biosensor and methods of use thereofCYGNUS THERAPEUTIC SYSTEMS·Filed 2004·Granted Nov 9, 2004·362 cites·29 claims
- 2394US6723340B2Optimal polymer mixtures for gastric retentive tabletsDEPOMED INC·Filed 2001·Granted Apr 20, 2004·299 cites·19 claims
- 2493US6587705B1Biosensor, iontophoretic sampling system, and methods of use thereofFiled 1999·Granted Jul 1, 2003·551 cites·63 claims
- 2592US5064654AMixed solvent mutually enhanced transdermal therapeutic systemCIBA GEIGY CORP·Filed 1990·Granted Nov 12, 1991·166 cites·11 claims
- 2691US9980903B2Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tractBERNER BRET·Filed 2011·Granted May 29, 2018·14 cites·13 claims
- 2791US7405238B2Pharmacological inducement of the fed mode for enhanced drug administration to the stomachDEPOMED INC·Filed 2002·Granted Jul 29, 2008·36 cites·5 claims
- 2890US9597338B2Shell-and-core dosage form approaching zero-order drug releaseDEPOMED INC·Filed 2014·Granted Mar 21, 2017·9 cites·24 claims
- 2990US9301934B2Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tractDEPOMED INC·Filed 2015·Granted Apr 5, 2016·9 cites·6 claims
- 3090US7736667B2Shell-and-core dosage form approaching zero-order drug releaseDEPOMED INC·Filed 2002·Granted Jun 15, 2010·26 cites·55 claims
- 3189US9993531B2Formulation for oral administration of proteinsALVINE PHARMACEUTICALS INC·Filed 2016·Granted Jun 12, 2018·4 cites·7 claims
- 3289US8802157B2Methods of treatment using a gastric retained gabapentin dosage formDEPOMED INC·Filed 2013·Granted Aug 12, 2014·7 cites·13 claims
- 3389US8592481B2Gastric retentive gabapentin dosage forms and methods for using sameDEPOMED INC·Filed 2012·Granted Nov 26, 2013·8 cites·12 claims
- 3489US7612112B2Methods of treatment using a gastric retained gabapentin dosageDEPOMED INC·Filed 2004·Granted Nov 3, 2009·20 cites·18 claims
- 3586US9000046B2Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tractBERNER BRET·Filed 2011·Granted Apr 7, 2015·8 cites·11 claims
- 3684US10772871B2Dexmedetomidine transdermal delivery devices and methods for using the sameTEIKOKU PHARMA USA INC·Filed 2014·Granted Sep 15, 2020·3 cites·21 claims
- 3784US2025304615A1Crystalline 19-nor c3,3-disubstituted c21-n-pyrazolyl steroidSAGE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3883US10987342B2Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidineTEIKOKU PHARMA USA INC·Filed 2014·Granted Apr 27, 2021·3 cites·37 claims
- 3983US10874642B2Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositionsTEIKOKU PHARMA USA INC·Filed 2019·Granted Dec 29, 2020·1 cites·16 claims
- 4082US11752107B25-hydroxytryptophan gastroretentive dosage formsEVECXIA THERAPEUTICS INC·Filed 2022·Granted Sep 12, 2023·1 cites·28 claims
- 4182US7873399B2Monitoring of physiological analytesANIMAS CORP·Filed 2007·Granted Jan 18, 2011·17 cites·4 claims
- 4282US4764382ADevice for controlled release drug deliveryHERCON LAB·Filed 1986·Granted Aug 16, 1988·57 cites·28 claims
- 4381US12358942B2Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroidSAGE THERAPEUTICS INC·Filed 2023·Granted Jul 15, 2025·0 cites·4 claims
- 4480US5925372AMixed solvent mutually enhanced transdermal therapeutic systemNOVARTIS AG·Filed 1991·Granted Jul 20, 1999·70 cites·11 claims
- 4579US9017667B2Dosage forms that facilitate rapid activation of barley protease zymogenBERNER BRET·Filed 2009·Granted Apr 28, 2015·2 cites·10 claims
- 4678US11266649B2Pharmaceutical formulationsCORVUS PHARMACEUTICALS INC·Filed 2019·Granted Mar 8, 2022·2 cites·16 claims
- 4778US10434150B2Methods and pharmaceutical compositions for treating celiac disease and gluten intoleranceALVINE PHARMACEUTICALS INC·Filed 2014·Granted Oct 8, 2019·4 cites·4 claims
- 4878US8329750B2Methods for treating vasomotor symptoms using GABA analogs in a gastric retentive dosage formBERNER BRET·Filed 2009·Granted Dec 11, 2012·2 cites·12 claims
- 4977US2024165105A1Topical naloxone compositions and methods for using the sameTEIKOKU PHARMA USA INC·Filed 2024·Application pending·0 cites
- 5076US8252332B2Gastric retained gabapentin dosage formDEPOMED INC·Filed 2010·Granted Aug 28, 2012·1 cites·24 claims
Showing the top 50 of 113 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →